EDWARD KELLY: Open Payments
NPI 1235122300 · DOWNINGTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 67 payments from 18 companies in 2025. Trend: 2023 $1,245 · 2024 $1,250 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $177 |
| GlaxoSmithKline, LLC. | 9 | $167 |
| Novo Nordisk Inc | 9 | $165 |
| ABBVIE INC. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Astellas Pharma US Inc | 3 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Lundbeck LLC | 3 | $55 |
| Verona Pharma, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $36 |
Products named: TRELEGY ELLIPTA, VRAYLAR, BREZTRI, JARDIANCE, Veozah, MOUNJARO, REXULTI, CAPLYTA.
Industry payments across PA — which companies pay providers there.
